|
Annual number of Hospital Episode Statistics finished consultant episodes with a primary diagnosis for an ADR (ICD-10 code) |
|||||||||
| ICD-10 |
1998–9 |
1999–00 |
2000–1 |
2001–2 |
2002–3 |
2003–4 |
2004–5 |
% Change 1998–2005 |
|
|
|
|||||||||
| D59.0/2 |
Drug induced haemolytic anaemia |
15 |
30 |
28 |
37 |
34 |
36 |
154 |
926.7 |
| D61.1 |
Drug induced aplastic anaemia |
101 |
116 |
114 |
186 |
182 |
162 |
241 |
138.6 |
| E03.2 |
Hypothyroidism due to medicaments |
23 |
23 |
12 |
12 |
19 |
13 |
26 |
13.0 |
| E27.3 |
Drug induced adrenocortical failure |
24 |
22 |
24 |
38 |
39 |
53 |
59 |
145.8 |
| F11 |
Mental disorders due to opioids |
4360 |
4287 |
4398 |
4187 |
3916 |
3690 |
3746 |
-14.1 |
| F13 |
Mental disorders due to sedatives/hypnotics |
223 |
247 |
247 |
239 |
232 |
206 |
189 |
-15.2 |
| F19 |
Mental disorders due to multiple psychoactive drugs |
3513 |
3137 |
2725 |
2643 |
2601 |
2690 |
2775 |
-21.0 |
| G21.0 |
Malignant neuroleptic syndrome |
101 |
106 |
121 |
108 |
102 |
93 |
128 |
26.7 |
| G21.1 |
Drug induced Parkinsonism |
145 |
115 |
124 |
133 |
112 |
108 |
149 |
2.8 |
| G24.0 |
Drug induced dystonia |
149 |
130 |
145 |
130 |
115 |
152 |
109 |
-26.8 |
| G25.1/4/6 |
Drug induced extrapyramidal syndrome/chorea/tics |
136 |
146 |
110 |
125 |
44 |
51 |
48 |
-64.7 |
| G72.0 |
Drug induced myopathy |
47 |
53 |
51 |
51 |
57 |
39 |
55 |
17.0 |
| H91.0 |
Ototoxic hearing loss |
2 |
5 |
3 |
3 |
2 |
U/C1 |
U/C |
U/C |
| I42.7 |
Drug induced cardiomyopathy |
25 |
25 |
53 |
38 |
67 |
77 |
61 |
144.0 |
| J70.2/3/4 |
Drug induced interstitial lung disorders |
54 |
45 |
43 |
43 |
86 |
71 |
94 |
74.1 |
| K71 |
Drug induced liver disease |
406 |
318 |
372 |
351 |
459 |
437 |
448 |
10.3 |
| L56.0/1 |
Drug induced phototoxicity |
4 |
5 |
2 |
4 |
1 |
3 |
5 |
25.0 |
| M10.2 |
Drug induced gout |
30 |
27 |
13 |
24 |
22 |
22 |
34 |
13.3 |
| M32.0 |
Drug induced systemic lupus erythematosus |
17 |
20 |
12 |
13 |
14 |
10 |
26 |
52.9 |
| M34.2 |
Drug induced systemic sclerosis |
3 |
3 |
4 |
3 |
U/C |
U/C |
U/C |
U/C |
| N14 |
Drug induced nephropathy |
60 |
69 |
92 |
85 |
100 |
318 |
414 |
590.0 |
| T88.3 |
Malignant hyperthermia due to anaesthesia |
6 |
4 |
10 |
3 |
3 |
5 |
4 |
-33.3 |
| T88.6 |
Drug induced anaphylaxis |
366 |
435 |
399 |
384 |
375 |
469 |
563 |
53.8 |
| T88.7 |
Unspecified adverse drug effect |
696 |
737 |
721 |
602 |
664 |
748 |
1068 |
53.4 |
|
|
|||||||||
| Total |
10506 |
10105 |
9823 |
9442 |
9246 |
9453 |
10396 |
-1.0 |
|
|
1U/C – unclassified: data not available due to a coding change | |||||||||
Patel et al. BMC Clinical Pharmacology 2007 7:9 doi:10.1186/1472-6904-7-9 |
|||||||||